# PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation

> **NCT03996772** · PHASE3 · COMPLETED · sponsor: **Imperial College London** · enrollment: 319 (actual)

## Conditions studied

- Atrial Fibrillation
- Intracerebral Hemorrhage

## Interventions

- **DRUG:** Apixaban Oral Tablet
- **DRUG:** Dabigatran
- **DRUG:** Edoxaban Tablets
- **DRUG:** Rivaroxaban

## Key facts

- **NCT ID:** NCT03996772
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-03
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 319 (ACTUAL)
- **Last updated:** 2025-01-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03996772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03996772, "PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03996772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*